Month: August 2021

NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) — Warner Music Group Corp. (“Warner Music Group” or “WMG”) announced today that through its wholly owned subsidiary WMG Acquisition Corp. (the “Company”) it has commenced a private offering (the “Notes Offering”) of euro-denominated senior secured notes (the “Notes”). The Company intends to use the net proceeds of the Notes Offering, together with cash on hand, to fund the conditional redemption of all of the Company’s outstanding 3.625% senior secured notes due 2026 which have been called for redemption on August 16, 2021. In the event that the conditions specified in any notice of redemption are not satisfied, such redemption will not occur. The Notes will be offered in a private offering exempt from the registration requirements of the United States Securities Act of 1933, as amended...

Credit Agricole Assurances would like to announce the publication today of its half-year-2021 consolidated financial statements. This document is available on Crédit Agricole Assurances’ website (https://www.ca-assurances.com/en/Investors)AttachmentCommuniqué de mise à disposition comptes conso 30.06.21 EN

The first semester of 2021 has been marked by a strong rebound in business, particularly on Crédit Agricole Assurances’ priority lines, despite a context of persistent health crisis. Crédit Agricole Assurances continued the diversification of its product mix towards protection of assets & individuals and unit-linked products in early 2021. At the end of June 2021, the Group recorded a growth of 24.6%1 of the revenues in its priority lines of business2 compared with the first half of 2020 (versus a 23.3% growth compared with the end of June 2019 and 33.0% compared with the end of June 2018). Including euro-denominated inflows, Crédit Agricole Assurances posted revenues of €19.5 billion, up 32.9%2 compared with the first semester of 2020 (versus a decrease of 5.1% compared with the end of June 2019 and a growth of 12.6% compared with...

Good progress in the projects towards important clinical events SECOND QUARTER IN BRIEFActive Biotech and NeoTX announce FDA clearance of IND for phase II clinical trial of naptumomabEVENTS AFTER THE END OF THE PERIODActive Biotech provided status update on the progress in its clinical naptumomab project Active Biotech’s partner NeoTX hosted KOL webinar on overcoming checkpoint inhibitor resistance, featuring combination with naptumomab as one approachFinancial summary  SEK M Apr-Jun Jan-Jun Full-year  2021 2020 2021 2020 2020           Net sales – – – 0.5 6.7Operating profit/loss -12.6 -10.1 -22.4 -19.9 -32.3Profit/loss after tax -12.6 -9.8 -22.4 -19.9 -32.2Earnings per share (SEK) -0.06 -0.06 -0.11 -0.12 -0.19Cash and cash equivalents (at close of period)     78.5 38.2 26.2                 For...

HighlightsRestructuring of Mkango and Talaxis’ interests in both the Songwe Hill Rare Earths Project and Maginito simplifies and optimises the Company’s ownership structure prior to delivery of the Songwe Hill Feasibility Study, and significantly enhances its growth potential:Mkango to increase ownership of the Songwe Hill Rare Earths Project and of Maginito to 100% in a £13m share transaction with Talaxis Mkango retains all offtake rights relating to Songwe Hill, Maginito and the 100% owned Pulawy Separation Plant project in PolandComplementary £5.52m fundraising at a 2.9% premium to its five-day VWAP, including a £700,000 investment by Non-Executive Chairman Derek Linfield Mkango is fully funded to complete the Feasibility Study for the Songwe Hill Rare Earths Project, targeted for completion in Q1 2022 Mkango now positioned...

Study will assess the benefit of combining UV1 with standard of care pembrolizumab Topline data expected in 2023Oslo, 5 August 2021: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announced that the first patient has been enrolled in FOCUS, an investigator-led Phase II randomized clinical trial in head-and-neck cancer of the Company’s telomerase cancer vaccine, UV1, in combination with the checkpoint inhibitor pembrolizumab. FOCUS is one of Ultimovacs’ four Phase II trials of UV1 in combination with various immunotherapy agents across four different cancer indications. The primary endpoint of FOCUS is progression-free survival rate at 6 months, with readout of topline results expected in 2023. “Initiation of recruitment in FOCUS adds further momentum to...

In an effort to strengthen the management efficiency of Akropolis Group, the company that owns and manages shopping and entertainment centres in Lithuania and Latvia, an audit committee has been established by the decision of Vilniaus Prekyba, the company’s sole shareholder. Three persons – Eglė Čiužaitė and Šarūnas Radavičius as two independent members, and Vilniaus Prekyba’s financial controller Lukas Bendoraitis – were appointed as members of the Audit Committee for a term of four years. In addition, Mr Radavičius was elected Chairman of the Audit Committee. The decision to establish an audit committee for Akropolis Group was taken with the aim to further improve the business transparency and efficiency of the leading Baltic shopping centre development and management company, and to make sure that the financial and operating decisions...

HighlightsGAAP net income attributable to the partners and preferred unitholders of $53.3 million and GAAP net income per common unit of $0.53 in the second quarter of 2021. Adjusted net income(1) attributable to the partners and preferred unitholders of $57.0 million and adjusted net income per common unit of $0.57 in the second quarter of 2021 (excluding other items listed in Appendix A to this release). Total adjusted EBITDA(1) of $183.5 million in the second quarter of 2021. The Partnership’s LNG fleet is 98 percent fixed for the remainder of 2021, and 89 percent fixed for 2022. Current strong LNG shipping fundamentals expected to persist into 2022.HAMILTON, Bermuda, Aug. 05, 2021 (GLOBE NEWSWIRE) — Teekay GP L.L.C., the general partner (the General Partner) of Teekay LNG Partners L.P. (Teekay LNG or the Partnership) (NYSE:...